Business Context and Reporting Period
This Form 8-K Current Report was filed by Dandrit Biotech USA, Inc. (not Lunai Bioworks Inc.) on April 5, 2017, covering events occurring on March 30, 2017. The registrant is a Delaware corporation with principal executive offices in Copenhagen, Denmark.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On March 30, 2017, the Board of Directors executed immediate leadership changes:
- Departures: Eric J. Leire was terminated as Chief Executive Officer (CEO) and Chief Financial Officer (CFO) and resigned as a director.
- Appointments: Aldo Petersen was appointed as CEO, and Soren Degn was appointed as CFO, both effective immediately.
Management Commentary and Background
The filing provides biographical details for the new officers but contains no forward-looking guidance, risk factors, or discussion of contingencies related to financial performance.
- Aldo Petersen (New CEO): Chairman of LiqTech International, Inc. since 2011; former CEO of APE Invest A/S; founder of Telepartner A/S; experienced investor in renewable energy and sports franchises.
- Soren Degn (New CFO): CFO of LiqTech International, Inc. since 2011; former CFO of Guava, Advance Renewable Energy Ltd., and EuroTrust; former financial controller at Kampsax and auditor at KPMG.
The company confirmed there are no undisclosed arrangements or transactions related to these appointments.
Investor Verification Checklist
- Verify the correct registrant name is Dandrit Biotech USA, Inc., as the input metadata referenced "Lunai Bioworks Inc."
- Confirm the immediate departure of Eric J. Leire from all executive and director roles.
- Review the professional backgrounds of Aldo Petersen and Soren Degn to assess their fit for the company's strategic direction.
- Check subsequent filings for any financial impact or strategic shifts resulting from this leadership transition.